| 13623 |
Leronlimab (Pro 140) Cliff Notes What is it?  (37) |
trding |
12/24/2019 8:09:27 PM |
| 112006 |
Leronlimab - Disease List (currently 90) (updated (28) |
ohm20 |
12/09/2021 8:15:12 AM |
| 144440 |
Leronlimab Regulator List (a work in progress) = (14) |
ohm20 |
06/12/2024 7:33:56 PM |
| 145805 |
Here's some basics on the science - Leronlimab (43) |
ohm20 |
08/21/2024 12:48:53 PM |
|
62167 |
I took it as adding a secondary endpoint of (4) |
MarcS |
10/20/2020 9:14:21 AM |
|
62166 |
Clearly. Blafarm, seems like you are trying (3) |
CDiddy |
10/20/2020 9:13:33 AM |
|
62165 |
I agree with everything you said, but I believe |
invisioner |
10/20/2020 9:12:49 AM |
|
62164 |
Based on the guidance provided by the DSMC, (2) |
ClosetInvestor |
10/20/2020 9:10:13 AM |
|
62163 |
293rd by beginning of November is not likely. We  (3) |
CDiddy |
10/20/2020 9:05:07 AM |
|
62162 |
Neither the DSMC or FDA are going to assume it's |
ohm20 |
10/20/2020 8:58:54 AM |
|
62161 |
A reply at ihub to Grip It and Sip It that's sure (6) |
ohm20 |
10/20/2020 8:57:13 AM |
|
62160 |
How do people feel funding factors into this (1) |
SAF |
10/20/2020 8:56:09 AM |
|
62159 |
Interesting. Thanks! (1) |
lorbas |
10/20/2020 8:50:29 AM |
|
62157 |
This is a very interesting question. imo, we (2) |
TechGuru |
10/20/2020 8:48:25 AM |
|
62153 |
If data was forwarded it would be a request for |
ohm20 |
10/20/2020 8:41:09 AM |
|
62152 |
With 23% bioavailability for Maraviroc I wonder (2) |
ohm20 |
10/20/2020 8:37:43 AM |
|
62151 |
Cytodyn crew can't be that stupid to keep making (2) |
mtruong34 |
10/20/2020 8:37:26 AM |
|
62150 |
So, this is the news we were expecting. Main (24) |
TechGuru |
10/20/2020 8:37:04 AM |
|
62149 |
I prefer it this way as far as eua ... No point |
Bw |
10/20/2020 8:32:38 AM |
|
62148 |
could mean that Amarex submitted data to the |
ClosetInvestor |
10/20/2020 8:31:05 AM |
|
62147 |
Interesting. Thanks |
jk1550 |
10/20/2020 8:28:48 AM |
|
62146 |
This is solid news. Now the number 1 question for |
jeff67 |
10/20/2020 8:27:41 AM |
|
62145 |
For an EUA to be granted, doesnt Cydy have to |
CrazyRon |
10/20/2020 8:26:48 AM |
|
62143 |
To my knowledge e.g. the dexamethasone study used (1) |
lorbas |
10/20/2020 8:24:29 AM |
|
62141 |
Release the unblinded data, and PR the whole (6) |
CaptnAmerca |
10/20/2020 8:19:06 AM |
|
62140 |
The odds of the FDA giving any input yet are (13) |
JLang |
10/20/2020 8:16:25 AM |
|
62139 |
lorbas, why do we need a 2-tailled distribution? |
jk1550 |
10/20/2020 8:15:06 AM |
|
62138 |
B Patterson PR. excerpt Maraviroc, an oral (1) |
dfwl28 |
10/20/2020 8:11:30 AM |
|
62137 |
I thought I read something from the FDA's website |
Eyedr |
10/20/2020 8:11:30 AM |
|
62136 |
https://www.prnewswire.com/news-releases/incelldx |
lorbas |
10/20/2020 8:07:37 AM |
|
62135 |
That Cytodyn is "seeking ongoing guidance from (3) |
ohm20 |
10/20/2020 8:02:21 AM |
|
62134 |
I agree. At face value its hard to read the (1) |
SAF |
10/20/2020 7:59:08 AM |
|
62133 |
Blafarm, Please tell me what is really achieved |
jk1550 |
10/20/2020 7:56:31 AM |
|
62132 |
Figured, good point. |
Riztheinvestor |
10/20/2020 7:56:13 AM |
|
62131 |
"If the DSMB reports that the clinical trial |
Riztheinvestor |
10/20/2020 7:55:05 AM |
|
62130 |
SAF, I believe you are 100% correct, that DSMC (6) |
CTMedic |
10/20/2020 7:50:46 AM |
|
62129 |
That EUA is based on risk/benefit analysis and (5) |
ohm20 |
10/20/2020 7:47:44 AM |
|
62128 |
Odds will be high that none in the LLMab arm need (2) |
blafarm |
10/20/2020 7:47:37 AM |
|
62127 |
Re: 42 day survival, with so many critical (1) |
JLang |
10/20/2020 7:43:13 AM |
|
62126 |
That's $3.24 USD +/- (2.74 euros) in case you |
Eyedr |
10/20/2020 7:42:33 AM |
|
62125 |
Pushes any positive news out to @ January 20th. (2) |
Boatbuilder |
10/20/2020 7:42:25 AM |
|
62124 |
Ohm, do you think unblinding now would be a good |
generactor |
10/20/2020 7:41:43 AM |
|
62123 |
So, they ARE changing the endpoint? It is |
invisioner |
10/20/2020 7:41:27 AM |
|
62120 |
DSMC also requests another data review when (3) |
ohm20 |
10/20/2020 7:39:22 AM |
|
62119 |
https://www.bloomberg.com/quote/296:GR Up 15% on |
Eyedr |
10/20/2020 7:39:17 AM |
|
62118 |
Odds are that stat sig was met, but they're just (1) |
JLang |
10/20/2020 7:37:15 AM |
|
62117 |
Playing with some numbers for 75% enrollment... |
lorbas |
10/20/2020 7:35:51 AM |
|
62116 |
We should have at least 5 additional sites in the (1) |
ohm20 |
10/20/2020 7:33:29 AM |
|
62115 |
Well, best case scenario might be enrollment in 4 (5) |
blafarm |
10/20/2020 7:28:35 AM |
|
62114 |
Wait, why 42? I am thinking 28. Where does the 42 |
invisioner |
10/20/2020 7:28:17 AM |
|
62113 |
Great summary of the issues and history of these (3) |
JLang |
10/20/2020 7:27:05 AM |
|
62112 |
I totally agree with and also feel the (1) |
invisioner |
10/20/2020 7:27:05 AM |
|
62111 |
It's obviously 42 days after the 293rd patient is (8) |
ohm20 |
10/20/2020 7:23:08 AM |
|
62110 |
And furthermore, if the trial was close to a p (5) |
invisioner |
10/20/2020 7:22:18 AM |
